|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.25 TWD | +1.79% |
|
-.--% | - |
| 04-26 | UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-08-12 | UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 1.68B 52.44M 45.87M 42.31M 39.08M 74.15M 5B 75.4M 506M 199M 2.46B 197M 193M 8.47B | P/E 2024 |
-9.63x | P/E 2025 | -5.68x |
|---|---|---|---|---|---|
| Enterprise Value | 1.97B 61.45M 53.75M 49.57M 45.79M 86.88M 5.86B 88.34M 592M 233M 2.89B 231M 226M 9.92B | EV / Sales 2024 |
3.58x | EV / Sales 2025 | 3.83x |
| Free-Float |
27.79% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.79% |
| 3 years | 10 |  | 38.5 |
| 5 years | 10 | | 202.59 |
| 10 years | 8.34 | | 288.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jung Kuang Yang
CEO | Chief Executive Officer | - | - |
Meng Han Hsu
DFI | Director of Finance/CFO | - | 2016-04-10 |
Ying Yun Fan
ADM | Chief Administrative Officer | - | 2015-02-28 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Yun Fan
BRD | Director/Board Member | - | 2020-06-29 |
Yan Ning Kuo
BRD | Director/Board Member | - | 2020-06-29 |
Yao Hui Wei
BRD | Director/Board Member | - | 2020-06-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.79% | -.--% | -.--% | -59.38% | 52.44M | |
| -2.33% | -2.09% | +49.88% | +170.51% | 1,060B | |
| -0.82% | -2.30% | +63.79% | +62.00% | 619B | |
| -0.73% | -4.98% | +28.91% | +82.99% | 438B | |
| +0.33% | -1.17% | +31.07% | +27.09% | 333B | |
| -0.02% | -2.85% | +29.15% | +45.24% | 282B | |
| -3.89% | -11.22% | +22.81% | +27.30% | 267B | |
| +0.66% | -1.42% | -26.59% | -37.71% | 218B | |
| -0.06% | -2.88% | +23.07% | +62.33% | 196B | |
| -3.72% | -1.10% | +18.41% | +70.56% | 161B | |
| Average | -0.88% | -2.48% | +24.05% | +45.09% | 357.4B | |
| Weighted average by Cap. | -1.31% | -2.96% | +36.75% | +83.91% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 539M 16.79M 14.68M 13.54M 12.51M 23.74M 1.6B 24.14M 162M 63.55M 789M 63.04M 61.66M 2.71B | 514M 16.03M 14.02M 12.93M 11.94M 22.66M 1.53B 23.04M 155M 60.68M 753M 60.18M 58.87M 2.59B |
| Net income | -175M -5.44M -4.76M -4.39M -4.05M -7.69M -519M -7.82M -52.42M -20.58M -255M -20.42M -19.97M -878M | -296M -9.23M -8.07M -7.45M -6.88M -13.05M -880M -13.27M -88.99M -34.95M -434M -34.66M -33.91M -1.49B |
| Net Debt | 246M 7.68M 6.71M 6.19M 5.72M 10.85M 732M 11.04M 73.99M 29.06M 361M 28.82M 28.19M 1.24B | 289M 9M 7.87M 7.26M 6.71M 12.73M 858M 12.94M 86.77M 34.07M 423M 33.8M 33.06M 1.45B |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- 6562 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
